Pankaj Mohan - 15 May 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chairman, President and CEO, Director
Signature
/s/ John Harry Cross III, power of attorney
Issuer symbol
SONN
Transactions as of
15 May 2023
Net transactions value
+$82,867
Form type
4
Filing time
15 May 2023, 17:17:04 UTC
Previous filing
16 Mar 2023
Next filing
27 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Purchase $82,867 +371,600 +204% $0.2230 553,331 15 May 2023 Direct F1, F2
holding SONN Common Stock 570 15 May 2023 By Child
holding SONN Common Stock 66,478 15 May 2023 By Mohan Family Office F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.22 to $0.2274 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
F2 Includes unvested restricted stock units.
F3 Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.